scispace - formally typeset
C

Claudia Berman

Researcher at University of South Florida

Publications -  82
Citations -  6538

Claudia Berman is an academic researcher from University of South Florida. The author has contributed to research in topics: Sentinel lymph node & Breast cancer. The author has an hindex of 36, co-authored 82 publications receiving 6406 citations.

Papers
More filters
Journal ArticleDOI

Lymphatic mapping and sentinel node biopsy in the patient with breast cancer

TL;DR: This study confirms that lymphatic mapping is technically possible in the patient with breast cancer and that the Histologic characteristics of the SLN probably reflect the histologic characteristicsof the rest of the axillary lymph nodes.
Journal ArticleDOI

Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.

TL;DR: This study demonstrates that accurate SLN identification was obtained when all blue and hot lymph nodes were harvested as SLNs, and demonstrates that lymphatic mapping and SLN biopsy is most effective when a combination of vital blue dye and radiolabeled sulfur colloid is used.
Journal ArticleDOI

Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma

TL;DR: The use of intraoperative radiolymphoscintigraphy can improve the identification of all SLNs during selective lymphadenectomy, and was used to confirm the location of the SLN initially with the preoperative lymphoscintigram and the intraoperative vital blue dye injection.
Journal ArticleDOI

Molecular staging of malignant melanoma: correlation with clinical outcome.

TL;DR: The use of an RT-PCR assay for detection of submicroscopic melanoma metastases in SLNs improved the prediction of melanoma recurrence and overall survival over routine pathological examination.
Journal ArticleDOI

Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization.

TL;DR: RSL is as effective as WL for the excision of nonpalpable breast lesions and reduces the incidence of pathologically involved margins of excision, also reduces scheduling conflicts and may allow elimination of intraoperative specimen mammography.